Boardroom Alpha
Meeting calendar
BOW · Special meeting · Friday, November 13, 2026

Bowhead Specialty Holdings Inc

11 nominees · 4 ballot items.

Stockholders will vote on adoption of the merger agreement and approval of the merger, advisory approval of merger-related named executive officer compensation, and adjournment of the special meeting if necessary to solicit additional proxies.

Market cap
$1.1B
1Y TSR
+33.7%
Board grade
C-
Record date
Oct 12, 2026
Filing
DEFM14A
Filed Oct 14, 2026 · DEFM14A
Proposals

On the ballot4

  1. 1

    Merger Proposal

    ManagementBoard: FOR

    Adopt the Agreement and Plan of Merger dated August 2, 2026, and approve the merger and related transactions under which Trident Superior Inc. will merge into Bowhead Specialty Holdings Inc., with each eligible common share converted into the right to receive $34.00 in cash, subject to stated exceptions and appraisal rights.

    More detail

    The proposal asks stockholders to approve the merger agreement and the merger with American Family Mutual Insurance Company, S.I. The transaction would merge Trident Superior Inc. into Bowhead, with Bowhead surviving as a privately held company. Eligible common shares would be converted into the right to receive $34.00 in cash per share, without interest and subject to applicable withholding. Parent would own 100% of the surviving company after closing, and the common shares would cease trading on the NYSE and be deregistered under the Exchange Act. Approval requires both a majority of all outstanding common shares and a majority of the outstanding shares held by Subject Stockholders, excluding Parent, its subsidiaries, and Recused Directors. The Non-Recused Directors negotiated the transaction, obtained a fairness opinion from Ardea, and considered market premiums, the Company’s prospects, industry conditions, alternative transactions, and the limited interest from contacted third parties. They concluded that $34.00 was the highest price Parent was willing to offer and that the agreement’s terms and procedural protections supported approval. Stockholders retain appraisal rights if they satisfy the detailed requirements of Section 262 of the Delaware General Corporation Law. The Board therefore recommends that stockholders vote FOR the Merger Proposal.

  2. 2

    Compensation Advisory Proposal

    ManagementBoard: FOR

    Approve, on a non-binding advisory basis, the compensation that will or may become payable to the Company’s named executive officers and that is based on or otherwise relates to the merger.

    More detail

    The proposal asks stockholders to approve, on a non-binding advisory basis, merger-related compensation for the Company’s named executive officers. The disclosed arrangements include cash severance, equity award treatment, benefits, retention awards, post-closing incentive opportunities, and a potential tax gross-up for the chief executive officer. The proxy identifies estimated total merger-related compensation of $32,390,388 for Stephen Sills, $2,784,477 for Brad Mulcahey, and $4,727,297 for David Newman under the stated assumptions. The compensation reflects both single-trigger and double-trigger elements, with many payments dependent on a qualifying termination after the merger. Mr. Sills’ equity awards are generally deferred into a cash-funded arrangement subject to continued employment through the first anniversary, subject to specified accelerated vesting exceptions. Messrs. Mulcahey and Newman may receive retention bonuses, while Mr. Sills and Mr. Newman have post-closing employment arrangements with Parent-related entities. The proposal is required by Section 14A of the Exchange Act and provides stockholders an opportunity to express a view on the compensation disclosures. The vote is not a condition to closing, is not binding on the Company, the Board, or Parent, and the contractual arrangements are not subject to approval. The Board nevertheless recommends that stockholders vote FOR the Compensation Advisory Proposal.

  3. 3

    Adjournment Proposal

    ManagementBoard: FOR

    Approve adjournment or postponement of the special meeting if necessary to solicit additional proxies because there are insufficient votes to approve the Merger Proposal.

    More detail

    The proposal asks stockholders to authorize adjournment or postponement of the special meeting if additional time is needed to obtain approval of the Merger Proposal. The principal purpose is to permit the Company and its proxy solicitor to solicit additional proxies when the votes then present are insufficient. The Company states that it does not intend to submit the proposal for a vote if the Merger Proposal has already been approved. An approved adjournment could also provide time to address an insufficient quorum or distribute a legally required supplement or amendment to the proxy statement. Under the Merger Agreement, the Company may adjourn after consultation with Parent for these purposes and in certain circumstances required by law or regulators. Adjournment would allow the Company to seek votes from stockholders who have not voted or who previously voted in a manner that could be changed. The proposal does not itself approve the merger and does not alter the separate voting thresholds for the Merger Proposal. Because all proposals are expected to be non-routine, brokers cannot vote uninstructed shares on this matter. The Board recommends that stockholders vote FOR the Adjournment Proposal.

  4. 4

    Other Business

    Management

    Act upon any other business that may properly come before the special meeting or any adjournment or postponement thereof.

    More detail

    The notice includes a standard item allowing stockholders to act on other business that may properly come before the special meeting. No specific additional matter is identified in the proxy statement. The Board states that it was not aware of any such other business as of the proxy statement date. If a stockholder signs and returns a proxy without limiting the proxy authority, the named proxy holders may vote in their discretion on any properly presented matter. This discretionary authority is subject to applicable law and the Board’s stated understanding that the matter must be properly brought before the meeting. The item is distinct from the three substantive proposals concerning the merger, executive compensation, and adjournment. The filing does not identify a shareholder proponent or a separate management resolution beyond the general authorization. No explicit Board recommendation of FOR or AGAINST is provided for this routine catch-all item. Stockholders should therefore understand it as authorization for proxy holders to address unforeseen proper business rather than as a separately analyzed management initiative.

Director elections

Nominees on the ballot11

Independent
Tenure on this board
2.4 yrs
Independent
Tenure on this board
2.5 yrs
Also a director at
Kelly Services Inc (KELYA)
Not independent
Tenure on this board
2.4 yrs
Not independent
Tenure on this board
0.1 yrs
Also a director at
Forbright Inc (FRBT)
Not independent
Tenure on this board
2.5 yrs
Also a director at
James River Group Holdings Inc (JRVR)
Ownership

Top institutional holders10

Latest 13F quarter
1Gallatin Point Capital LLC27.2%8,968,445$268M
2American Family Investments, Inc.14.3%4,700,761$141M
3AMERICAN CENTURY COMPANIES INC6.3%2,081,072$62M
4VICTORY CAPITAL MANAGEMENT INC5.2%1,729,490$52M
5Polar Capital Holdings Plc4.6%1,500,000$45M
6VANGUARD CAPITAL MANAGEMENT LLC2.5%834,303$25M
7BlackRock, Inc.2.1%686,800$21M
8BlackRock, Inc.1.7%558,083$17M
9SILVERCREST ASSET MANAGEMENT GROUP LLC1.7%551,821$17M
10STATE STREET CORP1.3%427,643$13M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Bowhead Specialty Holdings Inc 2026 special meeting?
Bowhead Specialty Holdings Inc (BOW) holds its 2026 special shareholder meeting on Friday, November 13, 2026.
What is the record date for the Bowhead Specialty Holdings Inc 2026 meeting?
The record date for the Bowhead Specialty Holdings Inc 2026 meeting is Monday, October 12, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Bowhead Specialty Holdings Inc's 2026 meeting?
The board is presenting 11 director nominees at the Bowhead Specialty Holdings Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Bowhead Specialty Holdings Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Bowhead Specialty Holdings Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer